OPRX - OptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenue

OptimizeRx (OPRX) secured 19 new enterprise-level deals for 2021 providing access to the company's full suite of solutions and nationwide digital healthcare platform.The 19 deals are a part of the 46 deals in pipeline shared during 4Q20 earnings release; the conversion success rate is in addition to a higher-than-average renewal rate of existing engagements over the same period.In 2021, the company expects to exceed the 86% renewal rate it experienced in the last year."We are encouraged by the continued conversion of our pipeline into enterprise-level deals and the resulting buildup in our recurring revenue. As these more expansive enterprise deployments better address the need for greater digital connectivity for our clients, they also provide OptimizeRx with a more consistent revenue stream," CEO William Febbo commented.

For further details see:

OptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenue